Zobrazeno 1 - 10 of 44 pro vyhledávání: '"S M Hammer"'
1
Die Kurzform des Brief Symptom Inventory (BSI -18): erste Befunde zu den psychometrischen Kennwerten der deutschen Version
Autor: Harald-J. Freyberger, Matthias Rose, Gabriele Helga Franke, Hans-Jörgen Grabe, S M Hammer, S. Barnow, Carsten Spitzer, Bernd Löwe, Katja Wingenfeld
Publikováno v: Fortschritte der Neurologie · Psychiatrie. 79:517-523
The short version of the Brief Symptom Inventory (BSI-18) is an easily applicable, reliable and valid self-report measure in wide international use. It assesses the syndroms of somatisation, depression and anxiety by means of 6 items each. For the ps
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3bc76c906f253de0c6a8912534055692
https://doi.org/10.1055/s-0031-1281602
Zobrazit plný text záznamu
2
Evaluation of an infectivity standard for real-time quality control of human immunodeficiency virus type 1 quantitative micrococulture assays. Participating Laboratories of The AIDS Clinical Trials Group
Autor: N Khan, D Brambilla, F. B. Hollinger, E Siwak, P S Reichelderfer, H Farzadegan, R W Coombs, C Beatty, S Rasheed, James W. Bremer, S M Hammer, Walter A. Scott, S A Fiscus
Publikováno v: Journal of Clinical Microbiology. 34:2312-2315
Quantitative microculture assays of cryopreserved human immunodeficiency virus type 1-infected cell suspensions and culture supernatants were compared among seven assays sites. There was no significant change in titer during 1 year of storage. The ov
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b7555b6578c0e9a7ba6b41c00420f4b
https://doi.org/10.1128/jcm.34.9.2312-2315.1996
Zobrazit plný text záznamu
3
MAJOR INFECTIOUS COMPLICATIONS AFTER ORTHOTOPIC LIVER TRANSPLANTATION AND COMPARISON OF OUTCOMES IN PATIENTS RECEIVING CYCLOSPORINE OR FK506 AS PRIMARY IMMUNOSUPPRESSION
Autor: Susan Hadley, Matthew H. Samore, Adolf W. Karchmer, S M Hammer, R L Jenkins, W D Lewis
Publikováno v: Transplantation. 59:851-858
A retrospective cohort study was conducted to determine the incidence of major infectious complications after orthotopic liver transplantation and to compare outcomes in patients receiving either cyclosporine (CsA) or FK506 (tacrolimus) as primary im
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::15e5e4ab8de61309da3369f4e406d6b5
https://doi.org/10.1097/00007890-199503000-00009
Zobrazit plný text záznamu
5
Meta-analysis of five randomized controlled trials comparing continuation of zidovudine versus switching to didanosine in HIV-infected individuals
Autor: J M, Raboud, J S, Montaner, S, Rae, J, Kahn, S M, Hammer, D A, Katzenstein, A, Pavia, R, Dolin, M D, Hughes, A, Cross, M, Beltangady, J, Gatell, L, Dunkle, L, Smaldone
Publikováno v: Antiviral therapy. 2(4)
A meta-analysis of the original data from 2411 patients in the ACTG 116A, ACTG116B/117, ACTG175, BMS010 and CTN002 trials was conducted to improve the estimate of the effect of switching from zidovudine to didanosine on rates of clinical progression,
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::7096a1db14deafa718b7c04d0a3d9573
https://pubmed.ncbi.nlm.nih.gov/11327443
Zobrazit plný text záznamu
6
Abacavir-lamivudine-zidovudine vs indinavir-lamivudine-zidovudine in antiretroviral-naive HIV-infected adults: A randomized equivalence trial
Autor: S, Staszewski, P, Keiser, J, Montaner, F, Raffi, J, Gathe, V, Brotas, C, Hicks, S M, Hammer, D, Cooper, M, Johnson, S, Tortell, A, Cutrell, D, Thorborn, R, Isaacs, S, Hetherington, H, Steel, W, Spreen
Publikováno v: JAMA. 285(9)
Abacavir, a nucleoside analogue, has demonstrated suppression of human immunodeficiency virus (HIV) replication alone and in combination therapy. However, the role of abacavir in a triple nucleoside combination regimen has not been evaluated against
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::0827a360788db6f0f51973dbe9fe77ba
https://pubmed.ncbi.nlm.nih.gov/11231752
Zobrazit plný text záznamu
7
Differences between women and men in adverse events and CD4+ responses to nucleoside analogue therapy for HIV infection. The Aids Clinical Trials Group 175 Team
Autor: J S, Currier, C, Spino, J, Grimes, C B, Wofsy, D A, Katzenstein, M D, Hughes, S M, Hammer, D J, Cotton
Publikováno v: Journal of acquired immune deficiency syndromes (1999). 24(4)
To prospectively examine differences in baseline characteristics and study outcomes between HIV-infected women and men during a clinical trial of nucleoside analogue therapy.ACTG 175 randomized HIV-infected patients with CD4+ counts between 200 and 5
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::708b1f78ec3ace1989d6dc3f9fca841d
https://pubmed.ncbi.nlm.nih.gov/11015147
Zobrazit plný text záznamu
9
Both serum HIV type 1 RNA levels and CD4+ lymphocyte counts predict clinical outcome in HIV type 1-infected subjects with 200 to 500 CD4+ cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study Team
Autor: S, Kim, M D, Hughes, S M, Hammer, J B, Jackson, V, DeGruttola, D A, Katzenstein
Publikováno v: AIDS research and human retroviruses. 16(7)
To evaluate HIV-1 RNA and CD4+ cell responses to therapy as predictors of clinical progression and to evaluate levels and trends of these markers prior to clinical failure, HIV-1 RNA measurements were retrospectively obtained on subjects who progress
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::a9259d64f0f8909d9bb90f464f1f71a3
https://pubmed.ncbi.nlm.nih.gov/10791875
Zobrazit plný text záznamu
10
The contribution of assay variation and biological variation to the total variability of plasma HIV-1 RNA measurements. The Women Infant Transmission Study Clinics. Virology Quality Assurance Program
Autor: D, Brambilla, P S, Reichelderfer, J W, Bremer, D E, Shapiro, R C, Hershow, D A, Katzenstein, S M, Hammer, B, Jackson, A C, Collier, R S, Sperling, M G, Fowler, R W, Coombs
Publikováno v: AIDS (London, England). 13(16)
To assess the specific contributions of assay variation and biological variation to the total variation of plasma HIV-1 RNA measured by the Roche Monitor assay and the extent to which batch assays reduced both assay variability and total variability
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::59c89826a395e2b7125013a4b714605e
https://pubmed.ncbi.nlm.nih.gov/10563712
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje